RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $791M
This Quarter Return
+34.16%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$913M
AUM Growth
+$115M
Cap. Flow
-$73.3M
Cap. Flow %
-8.04%
Top 10 Hldgs %
28.56%
Holding
108
New
15
Increased
30
Reduced
36
Closed
14
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
VIRX
101
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
-10,778
Closed -$272K
HMSY
102
DELISTED
HMS Holdings Corp.
HMSY
-98,300
Closed -$3.39M
RARX
103
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
-244,000
Closed -$5.77M
DPLO
104
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
-1,060,000
Closed -$5.19M
ACHN
105
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
-277,800
Closed -$1M
ARQL
106
DELISTED
Arqule Inc
ARQL
-200,000
Closed -$1.43M
MDCO
107
DELISTED
Medicines Co
MDCO
-153,000
Closed -$7.65M